Literature DB >> 11799280

Mutans streptococci, lactobacilli and caries experience in cystic fibrosis homozygotes, heterozygotes and healthy controls.

J K Aps1, G O Van Maele, G Claeys, L C Martens.   

Abstract

Mutans streptococci (MS) and lactobacillus (LB) counts (CRT Bacteria chair-side test) were compared and correlated with the respective caries experience (DMF) of cystic fibrosis (CF) homozygotes (n = 20), CF heterozygotes (n = 20) and healthy controls (n = 20). Each group of subjects was divided into two equal age groups: group A <20 years and group B >20 years. No significant differences were found regarding DMF between the three groups. CF heterozygotes had a significantly higher DMF-S than CF homozygotes (p = 0.040). This was also found in age group B (p<0.02), where it also counted for DMF-T (p<0.01). When in age group B, CF heterozygotes and controls were combined as one group, it was found that they had a significantly higher DMF-T (p = 0.031) and DMF-S (p = 0.008) than CF homozygotes. No significant differences in LB counts between the three groups were observed. CF homozygotes and those in age group A had significantly (p = 0.018 and p = 0.015) more low MS counts. LB and MS counts were positive and significantly correlated with DMF-T/-S in CF homozygotes and in the combined group of CF heterozygotes with controls (p< or = 0.05 and < or = 0.001). No correlations between bacterial counts and DMF were observed in CF heterozygotes. It can be concluded that despite the fact that CF homozygotes behave as high caries risk individuals, they did not have significantly more dental decay. More research is required in order to explore salivary, dietary and medication influences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11799280     DOI: 10.1159/000047483

Source DB:  PubMed          Journal:  Caries Res        ISSN: 0008-6568            Impact factor:   4.056


  8 in total

Review 1.  Dental caries prevalence in children and adolescents with cystic fibrosis: a qualitative systematic review and recommendations for future research.

Authors:  Donald L Chi
Journal:  Int J Paediatr Dent       Date:  2013-06-12       Impact factor: 3.455

2.  Salivary levels of mutans streptococci and Lactobacilli among Palestinian school children in East Jerusalem.

Authors:  Doron Steinberg; Lana Eskander; Avraham Zini; Harold Sgan-Cohen; Musa Bajali
Journal:  Clin Oral Investig       Date:  2013-08-18       Impact factor: 3.573

3.  Oral health and related factors in cystic fibrosis and other chronic respiratory disorders.

Authors:  A Narang; A Maguire; J H Nunn; A Bush
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

Review 4.  Dental treatment for people with cystic fibrosis.

Authors:  N Harrington; P J Barry; S M Barry
Journal:  Eur Arch Paediatr Dent       Date:  2016-05-04

5.  Evaluation of selective caries removal in deciduous teeth by a fluorescence feedback-controlled Er:YAG laser in vivo.

Authors:  Felix Krause; Andreas Braun; Gabriele Lotz; Susanne Kneist; Søren Jepsen; Jörg Eberhard
Journal:  Clin Oral Investig       Date:  2008-01-26       Impact factor: 3.573

6.  Age-related heterogeneity in dental caries and associated risk factors in individuals with cystic fibrosis ages 6-20 years: A pilot study.

Authors:  Donald L Chi; Margaret Rosenfeld; Lloyd Mancl; Whasun O Chung; Richard B Presland; Elise Sarvas; Marilynn Rothen; Alaa Alkhateeb; Sharon McNamara; Alan Genatossio; Isabel Virella-Lowell; Carlos Milla; JoAnna Scott
Journal:  J Cyst Fibros       Date:  2018-07-10       Impact factor: 5.482

7.  Elevated incidence of dental caries in a mouse model of cystic fibrosis.

Authors:  Marcelo A Catalán; Kathleen Scott-Anne; Marlise I Klein; Hyun Koo; William H Bowen; James E Melvin
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

8.  Estimation of Proinflammatory Factors in the Saliva of Adult Patients with Cystic Fibrosis and Dental Caries.

Authors:  Tomasz Hildebrandt; Anna Zawilska; Agata Trzcionka; Marta Tanasiewicz; Henryk Mazurek; Elżbieta Świętochowska
Journal:  Medicina (Kaunas)       Date:  2020-11-14       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.